leisure time -WSS

leisure time

author：leisure time 2025-09-03 03:45:29 - browse：14

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Devoted Health’s losses in Medicare Advantage persist

entertainment

WSS

States should stop sabotaging methadone treatment reform

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Supreme Court mifepristone arguments center on docs' right to sue

Why Novartis is going to walk from its acquisition of MorphoSys

Abortion pill Supreme Court ruling could impact entire drug industry

Problems with a popular proposal to regulate AI in health care

explore

leisure time

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Food as medicine: Medically tailored meals may get standardized

Continuity nursing helped my family in our darkest PICU moments

AstraZeneca stays mum on Medicare drug pricing negotiations

United colonoscopy coverage change 'may cost lives,' doctors say

Global cancer cases to surge 77% by 2050, WHO report says

Guidelines to prevent youth baseball injuries need more muscle

A protest over insulin prices is seen as a fight for life

As demand for Covid shots wanes, Moderna seeks its next success

Vertex Pharmaceuticals may move headquarters in Boston

knowledge

Medicare Advantage plans can’t deny care with AI, CMS warns

Readout Newsletter: Amgen, Regeneron, BGI Group and more

A single Democrat is willing to weaken Medicare negotiation power

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Primary care physicians play key roles in Alzheimer's management

Decaf coffee targeted by food safety group under obscure FDA rule

hotspot

entertainment

entertainment

explore